The Transformation of the Pharmaceutical Industry Is Putting Pressure on Finland and Europe
Companies are becoming increasingly selective about where they launch new medicines and where they invest in research.
In 2011 Simo Jääskeläinen was Medaffcon’s first recruitment. A couple of years ago Simo spread his wings to tackle new challenges and further develop his experience in different Market Access positions.
Simo has more than 12 years of experience from the pharmaceutical industry.
Now in June, to our great joy, Simo returned to Medaffcon, taking on the responsibility of leading our Market Access team. We are glad to welcome Simo back “home”!
At Medaffcon, this experience from the pharmaceutical and medtech industries, already exceeds 130 working years, all of which is harnessed to find the best solutions for our customers. Due to our experience and over 400 Medaffcon projects, we understand our customers’ playing field probably better than any of our competitors!

Companies are becoming increasingly selective about where they launch new medicines and where they invest in research.
Medaffcon’s Sales Lead Tomi "Tomppa" Vahevaara will retire on October 1st 2026. Tomppa leaves behind an exceptionally long career in the pharmaceutical industry spanning 45 years.
Medaffcon’s new Treatment Dynamics service provides insights into patient journeys, treatment progression, medication use and market dynamics through tailored patient-level real-world data analysis.